Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lund

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Haematologica|November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myelomaAric Anloague, Hayley M Sabol, Japneet Kaur, et al.
Bone|September 25, 2025
Ixazomib treatment has a dual effect on bone remodeling in patients with multiple myeloma: follow-up results from a phase 2 clinical studyMette Bøegh Levring, Marta Diaz-delCastillo, Michael Tveden Gundesen, et al.
Plos Biology|August 3, 2023
A previously unrecognized superfamily of macro-conotoxins includes an inhibitor of the sensory neuron calcium channel Cav2.3Celeste M Hackney, Paula Flórez Salcedo, Emilie Mueller, et al.
Scientific Reports|November 29, 2025
Cone snail venom-inspired somatostatin receptor 4 (SSTR<sub>4</sub>) agonists as new drug leads for peripheral painWalden E Bjørn-Yoshimoto, Iris Bea L Ramiro, Thomas Lund Koch, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditionsWalden E Bjørn-Yoshimoto, Iris Bea L Ramiro, Thomas Lund Koch, et al.
Leukemia|March 31, 2025
Senescence profiling of monoclonal gammopathies reveals paracrine senescence as a crucial defense against disease progressionGabriel Alvares Borges, Marta Diaz-delCastillo, Angelo J Guilatco, et al.
Nature Communications|August 20, 2024
Fish-hunting cone snail disrupts prey's glucose homeostasis with weaponized mimetics of somatostatin and insulinHo Yan Yeung, Iris Bea L Ramiro, Daniel B Andersen, et al.
Blood Cancer Journal|June 23, 2026
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patientsNiels W C J van de Donk, Fredrik Schjesvold, Bronno van der Holt, et al.
The Lancet. Oncology|September 17, 2023
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 studyNiels W C J van de Donk, Monique C Minnema, Bronno van der Holt, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Haematologica|November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myelomaAric Anloague, Hayley M Sabol, Japneet Kaur, et al.
Bone|September 25, 2025
Ixazomib treatment has a dual effect on bone remodeling in patients with multiple myeloma: follow-up results from a phase 2 clinical studyMette Bøegh Levring, Marta Diaz-delCastillo, Michael Tveden Gundesen, et al.
Plos Biology|August 3, 2023
A previously unrecognized superfamily of macro-conotoxins includes an inhibitor of the sensory neuron calcium channel Cav2.3Celeste M Hackney, Paula Flórez Salcedo, Emilie Mueller, et al.
Scientific Reports|November 29, 2025
Cone snail venom-inspired somatostatin receptor 4 (SSTR<sub>4</sub>) agonists as new drug leads for peripheral painWalden E Bjørn-Yoshimoto, Iris Bea L Ramiro, Thomas Lund Koch, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditionsWalden E Bjørn-Yoshimoto, Iris Bea L Ramiro, Thomas Lund Koch, et al.
Leukemia|March 31, 2025
Senescence profiling of monoclonal gammopathies reveals paracrine senescence as a crucial defense against disease progressionGabriel Alvares Borges, Marta Diaz-delCastillo, Angelo J Guilatco, et al.
Nature Communications|August 20, 2024
Fish-hunting cone snail disrupts prey's glucose homeostasis with weaponized mimetics of somatostatin and insulinHo Yan Yeung, Iris Bea L Ramiro, Daniel B Andersen, et al.
Blood Cancer Journal|June 23, 2026
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patientsNiels W C J van de Donk, Fredrik Schjesvold, Bronno van der Holt, et al.
The Lancet. Oncology|September 17, 2023
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 studyNiels W C J van de Donk, Monique C Minnema, Bronno van der Holt, et al.
Pageof 16